Showing results (161-170 of 447) with videos related to
Sort By:
Pageof 45
Stroke|January 29, 2015
Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failureRoopinder K Sandhu, Stefan H Hohnloser, Marc A Pfeffer, et al.Journal of Cardiovascular Electrophysiology|December 17, 2011
Celivarone for maintenance of sinus rhythm and conversion of atrial fibrillation/flutterAvinash R Khitri, Etienne M Aliot, Alessandro Capucci, et al.The American Journal of Cardiology|December 24, 2013
Prognostic usefulness of left ventricular hypertrophy by electrocardiography in patients with atrial fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study)Paolo Verdecchia, Gianpaolo Reboldi, Giuseppe Di Pasquale, et al.European Heart Journal|June 25, 2022
Rivaroxaban and aspirin vs. aspirin alone in Asian compared with non-Asian patients with chronic coronary artery disease or peripheral arterial disease: the COMPASS trialMasatsugu Hori, Jun Zhu, Yan Liang, et al.Stroke (Hoboken, N.J.)|January 26, 2026
Predictors of Intracranial Hemorrhage Volume Expansion in Patients Receiving Factor Xa Inhibitors in ANNEXA-4: Time and Severity Matter MostMauricio Concha, Lizhen Xu, MacKenzie Horn, et al.Journal of the American College of Cardiology|July 18, 2018
Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial FibrillationAnthony P Kent, Martina Brueckmann, Mandy Fraessdorf, et al.Circulation|November 16, 2011
Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE studyPeter R Kowey, Harry J G M Crijns, Etienne M Aliot, et al.The New England Journal of Medicine|March 11, 2011
Irbesartan in patients with atrial fibrillation, Salim Yusuf, Jeff S Healey, et al.Stroke|October 4, 2012
Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trialGreg C Flaker, John W Eikelboom, Olga Shestakovska, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 18, 2018
Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studiesTom F Brouwer, Reinoud E Knops, Valentina Kutyifa, et al.Pageof 45